Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
GIP (114) is a partial agonist of GIPR
Finest precision
The consistency across multiple large trials, run by different teams in different patient populations, gives clinicians real confidence that dual-receptor activation genuinely outperforms GLP-1 alone
We now have more than ten guidelines relating to hypercholesterolaemia, multiple diabetes guidelines, several heart failure guidelines, numerous kidney disease recommendations, and a growing number of cardiovascular prevention frameworks
US$ 23.72
US$ 21.35
US$ 21.44
US$ 26.42
US$ 28.79
US$ 21.23
US$ 29.37
US$ 26.53
US$ 26.70
US$ 24.79
